Cardiovascular consequences of recombinant DNA technology: interleukin-2.
Isner
J M
JM
St. Elizabeth's Hospital, Boston, Massachusetts.
Dietz
W A
WA
D006321:Heart / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D007022:Hypotension / Q000209:etiology; D007376:Interleukin-2 / Q000009:adverse effects*; D007694:Killer Cells, Natural / Q000276:immunology; D011669:Pulmonary Wedge Pressure; D012772:Shock, Septic / Q000503:physiopathology
D007376:Interleukin-2